BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
On 29 and 30 October 2025, the international consortium of the European research project OPADE met at the headquarters of the FONDAZIONE EBRIS in Salerno, Italy, to hold its second annual meeting. This important meeting marks a significant milestone in the progress…
During the 3rd IN-ARMOR Consortium Meeting in Biot, France, Work-Package leaders also met for the project’s 10th Management Board Meeting. This gathering provided an excellent opportunity to review project progress, align strategic priorities, and strengthen collaboration among all partners. By bringing the full consortium together, the meeting…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value